Screening for gynecological cancers

摘要: An estimated 17% of all new cancers in women worldwide are due to the cervix, ovary and uterus. Together, these account for 14.6% female cancer deaths. This is a significant societal economic burden, which can be limited through screening. In developed world, marked reductions 50–90% disease rates have been observed as result cervical By contrast, developing countries, where more than 85% cases deaths from this reported, challenges need overcome. Although cytology remains key component screening, newer molecular tests offer targeted, risk-attuned approach. The situation other two gynecological different. case ovarian screening has yet made with results trials high- low-risk populations still pending. Screening endometrial traditionally not advocated become symptomatic ...